|

177Lu-edotreotide Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Grupo Espanol de Tumores Neuroendocrinos1

Indications

  • Thymus Neoplasms1
  • Lung Neuroendocrine Neoplasm1
  • Neuroendocrine Tumors1
  • Lung Cancer1
  • Cancer1

Other1 trial

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.